A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Chronic Non-Cancer Pain

被引:0
|
作者
Webster, Lynn Roy
Yamada, Tadaaki
Ferreira, Juan Camilo Arjona
Davidson, Jennifer
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
901e
引用
收藏
页码:S1194 / S1194
页数:1
相关论文
共 50 条
  • [1] A phase II randomized, double-blind, placebo-controlled study to evaluate naldemedine for the treatment of opioid-induced constipation (OIC) in patients with cancer pain
    Boku, Narikazu
    Katakami, Nobuyuki
    Fujita, Shiro
    Oda, Koji
    Tauchi, Katsunori
    Nakata, Ken
    Shinozaki, Katsunori
    Okuno, Motoyasu
    Kawai, Yasukazu
    Kikukawa, Hiroaki
    Suzuki, Ryujiro
    Nakazawa, Hideo
    Kojima, Hiroshi
    Mizutani, Mitsuhiro
    Hara, Toru
    Yokota, Takaaki
    Suzuki, Yura
    Narabayashi, Masaru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer
    Katakami, Nobuyuki
    Oda, Koji
    Tauchi, Katsunori
    Nakata, Ken
    Shinozaki, Katsunori
    Yokota, Takaaki
    Suzuki, Yura
    Narabayashi, Masaru
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) : 1921 - +
  • [3] A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
    Webster, Lynn R.
    Yamada, Tadaaki
    Ferreira, Juan Camilo Arjona
    PAIN MEDICINE, 2017, 18 (12) : 2350 - 2360
  • [4] Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    Hamano, Jun
    Higashibata, Takahiro
    Kessoku, Takaomi
    Kajiura, Shinya
    Hirakawa, Mami
    Oyamada, Shunsuke
    Ariyoshi, Keisuke
    Yamada, Takeshi
    Yamamoto, Yoshiyuki
    Takashima, Yasuyuki
    Doki, Kosuke
    Homma, Masato
    Mathis, Bryan J.
    Jono, Tsumugi
    Ogata, Tomoki
    Tanaka, Kosuke
    Kasai, Yuki
    Iwaki, Michihiro
    Fuyuki, Akiko
    Nakajima, Atsushi
    Hayashi, Ryuji
    Ando, Takayuki
    Izawa, Naoki
    Kobayashi, Yuko
    Horie, Yoshiki
    Morita, Tatsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (35)
  • [5] Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study
    Webster, Lynn R.
    Nalamachu, Srinivas
    Morlion, Bart
    Reddy, Jyotsna
    Baba, Yuko
    Yamada, Tadaaki
    Ferreira, Juan C. Arjona
    PAIN, 2018, 159 (05) : 987 - 994
  • [6] A phase 2a, randomized, double-blind, placebo-controlled, single ascending-dose study to evaluate the safety and efficacy of naldemedine in patients with chronic non-cancer pain and opioid-induced bowel dysfunction
    Webster, L.
    Nagata, T.
    Yamada, T.
    Ferreira, J. Arjona
    JOURNAL OF PAIN, 2016, 17 (04): : S94 - S94
  • [7] Lubiprostone Is Well Tolerated in Chronic Non-Cancer Pain Patients With Opioid-Induced Constipation in Three Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Lichtlen, Peter
    Joswick, Taryn
    Woldegeorgis, Fasil
    Ueno, Ryuji
    GASTROENTEROLOGY, 2013, 144 (05) : S916 - S916
  • [8] Onset of Action of Naldemedine in the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain: Results from Two Randomized, Placebo-Controlled Phase 3 Trials
    Wild, James
    Hale, Martin
    Reddy, Jyotsna
    Yamada, Tadaaki
    Ferreira, Juan Camilo Arjona
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S236 - S237
  • [9] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Lubiprostone for the Treatment of Opioid-Induced Bowel Dysfunction in Patients With Chronic, Non-Cancer Pain
    Cryer, Byron L.
    Katz, Seymour
    Vallejo, Ricardo
    Scott, Charles B.
    Joswick, Taryn R.
    Dolecek, Gayle
    Ueno, Ryuji
    GASTROENTEROLOGY, 2010, 138 (05) : S129 - S129
  • [10] Time to Onset of Lubiprostone Treatment Effect in Chronic Non-Cancer Pain Patients With Opioid-Induced Constipation: Data From Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Joswick, Taryn
    Mareya, Shadreck M.
    Lichtlen, Peter
    Woldegeorgis, Fasil
    Ueno, Ryuji
    GASTROENTEROLOGY, 2013, 144 (05) : S540 - S540